Citations (27)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Jorge C. G. Blanco, Marina S. Boukhvalova, Trudy G. Morrison & Stefanie N. Vogel. (2018) A multifaceted approach to RSV vaccination. Human Vaccines & Immunotherapeutics 14:7, pages 1734-1745.
Read now
Read now
Donna M. MacDougall & Scott A. Halperin. (2016) Improving rates of maternal immunization: Challenges and opportunities. Human Vaccines & Immunotherapeutics 12:4, pages 857-865.
Read now
Read now
Claudia A Rivera, Roberto S Gómez, Rodrigo A Díaz, Pablo F Céspedes, Janyra A Espinoza, Pablo A González, Claudia A Riedel, Susan M. Bueno & Alexis M Kalergis. (2015) Novel therapies and vaccines against the human respiratory syncytial virus. Expert Opinion on Investigational Drugs 24:12, pages 1613-1630.
Read now
Read now
Patricia Kaaijk, Deborah E Kleijne, Mirjam J Knol, Irene A Harmsen, Olga JAE Ophorst & Nynke Y Rots. (2014) Parents’ attitude toward multiple vaccinations at a single visit with alternative delivery methods. Human Vaccines & Immunotherapeutics 10:8, pages 2483-2489.
Read now
Read now
Articles from other publishers (23)
Tino F Schwarz, Casey Johnson, Christine Grigat, Dan Apter, Peter Csonka, Niklas Lindblad, Thi Lien-Anh Nguyen, Feng F Gao, Hui Qian, Antonella N Tullio, Ilse Dieussaert, Marta Picciolato & Ouzama Henry. (2022) Three Dose Levels of a Maternal Respiratory Syncytial Virus Vaccine Candidate Are Well Tolerated and Immunogenic in a Randomized Trial in Nonpregnant Women. The Journal of Infectious Diseases 225:12, pages 2067-2076.
Crossref
Crossref
Wasef Na'amnih, Eias Kassem, Shebly Tannous, Viktoria Kagan, Athar Jbali, Elizabeth Hanukayev, Sarit Freimann, Uri Obolski & Khitam Muhsen. (2022) Incidence and risk factors of hospitalisations for respiratory syncytial virus among children aged less than 2 years. Epidemiology and Infection 150.
Crossref
Crossref
Zainab Saeed, Orene Greer & Nishel Mohan Shah. (2020) Is the Host Viral Response and the Immunogenicity of Vaccines Altered in Pregnancy?. Antibodies 9:3, pages 38.
Crossref
Crossref
Christopher R. Wilcox, Anna Calvert, Jane Metz, Eliz Kilich, Rachael MacLeod, Kirsten Beadon, Paul T. Heath, Asma Khalil, Adam Finn, Matthew D. Snape, Tushna Vandrevala, Tom Nadarzynski, Matthew A. Coleman & Christine E. Jones. (2019) Attitudes of Pregnant Women and Healthcare Professionals Toward Clinical Trials and Routine Implementation of Antenatal Vaccination Against Respiratory Syncytial Virus: A Multicenter Questionnaire Study. Pediatric Infectious Disease Journal 38:9, pages 944-951.
Crossref
Crossref
Eias Kassem, Wasef Na'amnih, Amna Bdair-Amsha, Hazar Zahalkah & Khitam Muhsen. (2019) Comparisons between ethnic groups in hospitalizations for respiratory syncytial virus bronchiolitis in Israel. PLOS ONE 14:4, pages e0214197.
Crossref
Crossref
R. Garg, L. Latimer, S. Gomis, V. Gerdts, A. Potter & S. van Drunen Littel-van den Hurk. (2019) Maternal vaccination with a novel chimeric glycoprotein formulated with a polymer-based adjuvant provides protection from human parainfluenza virus type 3 in newborn lambs. Antiviral Research 162, pages 54-60.
Crossref
Crossref
Manjiri Joshi & Robert M R Tulloh. (2018) Respiratory virus prophylaxis in congenital heart disease. Future Cardiology 14:5, pages 417-425.
Crossref
Crossref
Katherine H. Restori, Bharat T. Srinivasa, Brian J. Ward & Elizabeth D. Fixman. (2018) Neonatal Immunity, Respiratory Virus Infections, and the Development of Asthma. Frontiers in Immunology 9.
Crossref
Crossref
MS Boukhvalova, KC Yim & JCG Blanco. (2018) Cotton rat model for testing vaccines and antivirals against respiratory syncytial virus. Antiviral Chemistry and Chemotherapy 26, pages 204020661877051.
Crossref
Crossref
Cristina Capella, Supranee Chaiwatpongsakorn, Erin Gorrell, Zachary A Risch, Fang Ye, Sara E Mertz, Sara M Johnson, Melissa Moore-Clingenpeel, Octavio Ramilo, Asuncion Mejias & Mark E Peeples. (2017) Prefusion F, Postfusion F, G Antibodies, and Disease Severity in Infants and Young Children With Acute Respiratory Syncytial Virus Infection. The Journal of Infectious Diseases 216:11, pages 1398-1406.
Crossref
Crossref
Nicolás Gálvez, Jorge Soto & Alexis Kalergis. (2017) New Insights Contributing to the Development of Effective Vaccines and Therapies to Reduce the Pathology Caused by hRSV. International Journal of Molecular Sciences 18:8, pages 1753.
Crossref
Crossref
Jorge C.G. Blanco, Lioubov M. Pletneva, Raymonde O. Otoa, Mira C. Patel, Stefanie N. Vogel & Marina S. Boukhvalova. (2017) Preclinical assessment of safety of maternal vaccination against respiratory syncytial virus (RSV) in cotton rats. Vaccine 35:32, pages 3951-3958.
Crossref
Crossref
Anja Saso & Beate Kampmann. (2016) Vaccination against respiratory syncytial virus in pregnancy: a suitable tool to combat global infant morbidity and mortality?. The Lancet Infectious Diseases 16:8, pages e153-e163.
Crossref
Crossref
R. Garg, L. Latimer, Y. Wang, E. Simko, V. Gerdts, A. Potter & S. van Drunen Littel-van den Hurk. (2016) Maternal immunization with respiratory syncytial virus fusion protein formulated with a novel combination adjuvant provides protection from RSV in newborn lambs. Vaccine 34:2, pages 261-269.
Crossref
Crossref
Natasha Halasa, John Williams, Samir Faouri, Asem Shehabi, Sten H. Vermund, Li Wang, Christopher Fonnesbeck & Najwa Khuri-Bulos. (2015) Natural history and epidemiology of respiratory syncytial virus infection in the Middle East: Hospital surveillance for children under age two in Jordan. Vaccine 33:47, pages 6479-6487.
Crossref
Crossref
Marion F. Gruber. (2014) Global and National Initiatives to Facilitate Studies of Vaccines in Pregnant Women. Clinical Infectious Diseases 59:suppl_7, pages S395-S399.
Crossref
Crossref
Geeta K. Swamy & Rebecca Garcia-Putnam. (2014) Maternal Immunization to Benefit the Mother, Fetus, and Infant. Obstetrics and Gynecology Clinics of North America 41:4, pages 521-534.
Crossref
Crossref
Colleen Wegzyn, Lim Kai Toh, Gerard Notario, Sophie Biguenet, Kristina Unnebrink, Caroline Park, Doris Makari & Michael Norton. (2014) Safety and Effectiveness of Palivizumab in Children at High Risk of Serious Disease Due to Respiratory Syncytial Virus Infection: A Systematic Review. Infectious Diseases and Therapy 3:2, pages 133-158.
Crossref
Crossref
Roberto S. Gomez, Isabelle Guisle-Marsollier, Karen Bohmwald, Susan M. Bueno & Alexis M. Kalergis. (2014) Respiratory Syncytial Virus: Pathology, therapeutic drugs and prophylaxis. Immunology Letters 162:1, pages 237-247.
Crossref
Crossref
Iebe Rossey, Koen Sedeyn, Sarah De Baets, Bert Schepens & Xavier Saelens. (2014) CD8+ T cell immunity against human respiratory syncytial virus. Vaccine 32:46, pages 6130-6137.
Crossref
Crossref
Stefan Niewiesk. (2014) Maternal Antibodies: Clinical Significance, Mechanism of Interference with Immune Responses, and Possible Vaccination Strategies. Frontiers in Immunology 5.
Crossref
Crossref
Janyra A. Espinoza, Susan M. Bueno, Claudia A. Riedel & Alexis M. Kalergis. (2014) Induction of protective effector immunity to prevent pathogenesis caused by the respiratory syncytial virus. Implications on therapy and vaccine design. Immunology 143:1, pages 1-12.
Crossref
Crossref
Anurag Sharma, Rebecca Wendland, Biin Sung, Wenzhu Wu, Thomas Grunwald & Stefan Worgall. (2014) Maternal immunization with chimpanzee adenovirus expressing RSV fusion protein protects against neonatal RSV pulmonary infection. Vaccine 32:43, pages 5761-5768.
Crossref
Crossref